Matching slides 10,471
Current window 2,881-2,910
Pages 350
Rows per page 30
Slide type: Tractionclear collectionreset all

Slide type

2,881-2,910 of 10,471

filter-aware
12
Includes two bar charts showing primary and secondary endpoint results.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank Beat · Product1 hit
10
The slide uses an aerial photograph with annotations to delineate different phases of facility construction.Clever Leaves | SPAC Presentation Deck | 16 slides · Clever Leaves
Pitch deck Investment bank 1 hit
13
The slide uses a three-column comparison layout to detail the partnership.Clever Leaves | SPAC Presentation Deck | 16 slides · Clever Leaves
Pitch deck Investment bank 1 hit
10
The chart uses a cumulative area plot to visualize franchise growth over time.F45 | SPAC Presentation Deck | 52 slides · F45
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
18
The chart shows AUV growth over time for different franchise cohorts (2014-2019).F45 | SPAC Presentation Deck | 52 slides · F45
Pitch deck Investment bank 1 hit
29
Includes CAGR metrics for pre-COVID and COVID-impacted periods; highlights 2020 as a COVID year.F45 | SPAC Presentation Deck | 52 slides · F45
Pitch deck Investment bank 1 hit
34
The slide uses a geographic segmentation to show franchise health metrics and qualitative support initiatives.F45 | SPAC Presentation Deck | 52 slides · F45
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
35
Includes social media testimonials and survey statistics.F45 | SPAC Presentation Deck | 52 slides · F45
Pitch deck Investment bank 1 hit
37
Includes data on studio reopening counts and specific studio performance examples in Hong Kong and Hendersonville.F45 | SPAC Presentation Deck | 52 slides · F45
Pitch deck Investment bank 1 hit
19
The slide compares tumor volume growth curves (left) with histological H&E staining results (right) to demonstrate efficacy.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · Traction1 hit
20
The slide uses three distinct charts (two line graphs for different tumor types, one for large tumors) and a microscopy image to demonstrate therapeutic efficacy.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · Traction1 hit
25
The slide uses medical imaging to validate the efficacy of the therapeutic agent in diverse solid tumor environments.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
26
The slide demonstrates the stability of the drug's targeting mechanism over time, which is critical for multi-dose therapeutic regimens.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
31
The slide uses a standard preclinical study design (process flow) followed by two line charts comparing treatment efficacy.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
32
The slide uses a process diagram to explain the experimental design (re-challenge model) followed by a line chart showing tumor volume over time.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
33
The slide demonstrates the mechanism of action for the therapeutic effect, specifically highlighting T cell memory.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
40
Includes footnotes explaining the Series B tranche structure and pro forma cash calculation.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Loop · Quick Win Big Bet1 hit
19
The slide uses a visual comparison of app store ratings to establish market superiority in customer satisfaction.Lemonade | IPO Presentation Deck | 67 slides · Lemonade
Pitch deck Investment bank Beat · Interest1 hit
23
Lemonade | IPO Presentation Deck | 67 slidesLemonade | IPO Presentation Deck | 67 slides · Lemonade
Pitch deck Investment bank Beat · Desire1 hit
24
The chart uses a combination of a bar chart for customer counts and bracket annotations for annual PPC metrics.Lemonade | IPO Presentation Deck | 67 slides · Lemonade
Pitch deck Investment bank Beat · Desire1 hit
25
The chart displays a clear upward trend in revenue/premium growth over 13 quarters.Lemonade | IPO Presentation Deck | 67 slides · Lemonade
Pitch deck Investment bank Beat · Desire1 hit
26
The slide uses a 'before-after' comparison to demonstrate resilience during the COVID-19 pandemic.Lemonade | IPO Presentation Deck | 67 slides · Lemonade
Pitch deck Investment bank Beat · Desire1 hit
32
The chart illustrates a clear upward trend in customer conversion/graduation rates.Lemonade | IPO Presentation Deck | 67 slides · Lemonade
Pitch deck Investment bank Beat · Desire1 hit
33
The chart illustrates cohort-based spending growth over time.Lemonade | IPO Presentation Deck | 67 slides · Lemonade
Pitch deck Investment bank Beat · Desire1 hit
37
The chart illustrates operating leverage/scaling efficiency by showing a narrowing loss margin over time.Lemonade | IPO Presentation Deck | 67 slides · Lemonade
Pitch deck Investment bank Beat · Desire1 hit
39
Minimalist slide with a solid pink background.Lemonade | IPO Presentation Deck | 67 slides · Lemonade
Pitch deck Investment bank Beat · Desire1 hit
45
The chart uses a series of bars with labels 1/4X, 1/2X, 3/4X, 5/6X, X, 1 1/6X, 1 2/3X, 2X, 2 2/3X.Lemonade | IPO Presentation Deck | 67 slides · Lemonade
Pitch deck Investment bank Beat · ActionLoop · Cost Of Inaction1 hit
49
The chart shows a steady upward trend, reaching over 30% by Q1 2020.Lemonade | IPO Presentation Deck | 67 slides · Lemonade
Pitch deck Investment bank Beat · ActionLoop · Cost Of Inaction1 hit
51
The chart demonstrates the efficacy of the company's machine learning models in improving underwriting performance over time.Lemonade | IPO Presentation Deck | 67 slides · Lemonade
Pitch deck Investment bank Beat · Action1 hit
52
The chart uses a 'scissors' or 'crossover' visual to emphasize the divergence of two key performance metrics.Lemonade | IPO Presentation Deck | 67 slides · Lemonade
Pitch deck Investment bank Beat · Action1 hit